Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Forster

Showing results (121-130 of 157) with videos related to

Pageof 16
Sort By:
The British Journal of Dermatology|June 23, 2017
A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot studyA J Lowe, J C Su, K J Allen, et al.
Nature Communications|May 1, 2020
In-situ resonant band engineering of solution-processed semiconductors generates high performance n-type thermoelectric nano-inksAyaskanta Sahu, Boris Russ, Miao Liu, et al.
Cancers|March 28, 2024
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid TumorsFilip Janku, Grace M Choong, Mateusz Opyrchal, et al.
BMJ Open Respiratory Research|June 9, 2026
Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocolSindhu Bhaarrati Naidu, Gabrielle Guvensen, Honghan Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanomaJeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
Dendrimer-nanoparticle (DEP) delivery of cabazitaxel (DEP-cabazitaxel): A first-in-human phase 1/2 trial in patients with advanced solid tumoursRobert H Jones, David J Pinato, Martin D Forster, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 10, 2020
Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell CancerK J Harrington, S A Bhide, M D Forster, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 19, 2023
Biphenotypic sinonasal sarcoma: European multicentre case-series and systematic literature reviewMario Turri-Zanoni, Gianluca Dalfino, Matt Lechner, et al.
Plos Genetics|May 3, 2013
Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer typesCraig P Giacomini, Steven Sun, Sushama Varma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 28, 2021
Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1-Positive Advanced NSCLCRoy S Herbst, Edward B Garon, Dong-Wan Kim, et al.
Pageof 16

Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
The British Journal of Dermatology|June 23, 2017
A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot studyA J Lowe, J C Su, K J Allen, et al.
Nature Communications|May 1, 2020
In-situ resonant band engineering of solution-processed semiconductors generates high performance n-type thermoelectric nano-inksAyaskanta Sahu, Boris Russ, Miao Liu, et al.
Cancers|March 28, 2024
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid TumorsFilip Janku, Grace M Choong, Mateusz Opyrchal, et al.
BMJ Open Respiratory Research|June 9, 2026
Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocolSindhu Bhaarrati Naidu, Gabrielle Guvensen, Honghan Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanomaJeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
Dendrimer-nanoparticle (DEP) delivery of cabazitaxel (DEP-cabazitaxel): A first-in-human phase 1/2 trial in patients with advanced solid tumoursRobert H Jones, David J Pinato, Martin D Forster, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 10, 2020
Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell CancerK J Harrington, S A Bhide, M D Forster, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|January 19, 2023
Biphenotypic sinonasal sarcoma: European multicentre case-series and systematic literature reviewMario Turri-Zanoni, Gianluca Dalfino, Matt Lechner, et al.
Plos Genetics|May 3, 2013
Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer typesCraig P Giacomini, Steven Sun, Sushama Varma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 28, 2021
Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1-Positive Advanced NSCLCRoy S Herbst, Edward B Garon, Dong-Wan Kim, et al.
Pageof 16